At Rebrain Greece Munich, organised by the Ministry of Labour and Social Security on Saturday, 28 November 2026, in Munich, Elpen is taking part, strengthening its ties with Greek professionals living and working in Germany.
With more than 2,000 employees across the group and facilities in Pikermi, Keratea, Markopoulo, Marousi in Attica and Tripoli in Arcadia, Elpen continues to expand its footprint steadily.
At the same time, it continues to invest heavily in its people, creating new jobs and meaningful career development opportunities in Greece’s pharmaceutical industry.
Elpen’s presence in Munich also provides an opportunity for meaningful dialogue with Greeks abroad about the new opportunities emerging in Greece’s pharmaceutical sector and the prospects for building a career in Greece.
Commenting on Elpen’s participation in Rebrain Greece Munich, the Elpen Group’s HR director Dimitris Oikonomidis said:
“At Elpen, we believe that people are the driving force behind our growth and innovation.
Our participation in Rebrain Greece is an important opportunity to meet Greek scientists and professionals who have gained valuable experience and discuss with them the opportunities available today to build a dynamic career at Elpen.
We remain fully committed to strengthening Elpen’s reputation as a first-choice employer and creating the conditions for knowledge, talent and international experience to develop and contribute to the next chapter of Greece’s pharmaceutical industry.”.
Rebrain Greece Munich aims to foster professional connections between Greeks living and working in Germany and companies operating in Greece, creating the conditions for new professional partnerships and collaborations.
Similar events have already been held in London, Amsterdam, Düsseldorf, Stuttgart and New York, attracting more than 9,500 interested people, who had the opportunity to meet directly with 120 of the largest companies operating in Greece.